Institute of Physiological Chemistry, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.
Cell Mol Life Sci. 2024 Oct 26;81(1):441. doi: 10.1007/s00018-024-05478-8.
Signal peptide peptidase-like 2c (SPPL2c) is a testis-specific aspartyl intramembrane protease that contributes to male gamete function both by catalytic and non-proteolytic mechanisms. Here, we provide an unbiased characterisation of the in vivo interactome of SPPL2c identifying the ER chaperone calnexin as novel binding partner of this enzyme. Recruitment of calnexin specifically required the N-glycosylation within the N-terminal protease-associated domain of SPPL2c. Importantly, mutation of the single glycosylation site of SPPL2c or loss of calnexin expression completely prevented SPPL2c-mediated intramembrane proteolysis of all tested substrates. By contrast and despite rather promiscuous binding of calnexin to other SPP/SPPL proteases, expression of the chaperone was exclusively required for SPPL2c-mediated proteolysis. Despite some impact on the stability of SPPL2c most presumably due to assistance in folding of the luminal domain of the protease, calnexin appeared to be recruited rather constitutively to the protease thereby boosting its catalytic activity. In summary, we describe a novel, highly specific mode of intramembrane protease regulation, highlighting the need to systematically approach control mechanisms governing the proteolytic activity of other members of the aspartyl intramembrane protease family.
信号肽肽酶样 2c(SPPL2c)是一种睾丸特异性天冬氨酰内肽酶,通过催化和非蛋白水解机制为精子功能做出贡献。在这里,我们对 SPPL2c 的体内相互作用组进行了无偏倚的描述,鉴定出内质网伴侣蛋白 calnexin 是该酶的新结合伴侣。calnexin 的募集特别需要 SPPL2c N 端蛋白酶相关结构域内的 N-糖基化。重要的是,SPPL2c 中单个糖基化位点的突变或 calnexin 表达的缺失完全阻止了所有测试底物的 SPPL2c 介导的跨膜蛋白水解。相比之下,尽管 calnexin 与其他 SPP/SPPL 蛋白酶具有相当混杂的结合,但该伴侣蛋白的表达仅对 SPPL2c 介导的蛋白水解是必需的。尽管 calnexin 对 SPPL2c 的稳定性有一定影响(最可能是由于协助蛋白酶的腔结构域折叠),但 calnexin 似乎是相当组成性地被招募到蛋白酶上,从而提高其催化活性。总之,我们描述了一种新的、高度特异性的跨膜蛋白酶调节模式,强调需要系统地研究控制天冬氨酰内肽酶家族其他成员蛋白水解活性的调控机制。